Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 227-006-8 | CAS number: 5593-70-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
In vitro mutagenic activity of titanium tetrabutanolate has been evaluated in one study with bacterial cells and in two studies with mammalian cells. These studies are performed according to the current guidelines in accordance with GLP, and evaluated to be reliable without restrictions. Thus, it is justified to select all three studies as key studies.
Mutagenicity in bacterial test systems
A bacterial mutagenicity study by Verspeek-Rip C. M (2012) is considered reliable without restrictions as the study was performed in compliance with GLP according to OECD guideline 471. This study was conducted by using five strains of Salmonella typhimurium bacteria (TA98, TA100, TA1535, and TA1537) and Escherichia coli (WP2uvrA) with and without metabolic activation. Titanium tetrabutanolate was tested for its ability to induce mutations at the concentration of 3, 10, 33, 100, 333, 1 000, 3 330 and 5 000 µg/plate. The test substance did not induce mutations under conditions of this study.
Cytogenicity in mammalian cells
The potential of titanium tetrabutanolate to induce chromosome aberration was assessed in cultured peripheral human lymphocytes by Verbaan I. A. J (2013). This study is considered reliable without restrictions as the study was performed in compliance with GLP according to OECD guideline 473. Titanium tetrabutanolate was tested with and without metabolic activation in doses up to 1 000 µg/ml. The compound was not clastogenic in human lymphocyte assay either in the presence or absence of metabolic activation, i. e., it did not increase the number of polyploid cells and cells with endoreduplicated chromosomes in the cells.
Mutagenicity in mammalian cells
The potential gene mutagenic activity of titanium tetrabutanolate has been evaluated in L5178Y mouse lymphoma cells by Verspeek-Rip, C.M. (2013). The test method was comparable to OECD guideline 476 and the test was conducted in compliance with GLP. The test substance was tested in two independent experiments with modifications in the duration of treatment time and in the concentration of the metabolic activation system (S9-mix). Titanium tetrabutanolate was not mutagenic, both in the presence and absence of S9-mix.
The results from genotoxicity assays of titanium tetrabutanolate are universally negative. In addition, neither of the decomposition products (n-butanol and TiO2) of the target substance has classification entries for genotoxicity.
Justification for selection of genetic toxicity endpoint
Conclusion based on the following assays: Bacterial reverse mutation assay (Ames test); Mammalian cell gene mutation assay, In vitro mammalian chromosome aberration test.
Short description of key information:
Gene mutation (reverse mutation assay/Ames test): negative in all tested bacterial strains with and without metabolic activation (equivalent to OECD TG 471).
Chromosome aberration study in mammalian cells: negative, with and without metabolic activation (OECD 473).
Gene mutation study in mammalian cells: negative, with and without metabolic activation (OECD 476).
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Based on the results of in vitro bacterial gene mutation study, in vitro mammalian chromosomal aberration and gene mutation studies the substance has no potential to cause mutagenicity and genotoxicity. No classification is required according to the criteria of CLP regulation 1272/2008 and the EU directive 67/548/EEC.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.